Zobrazeno 1 - 10
of 13
pro vyhledávání: '"David C. Rice"'
Autor:
Alex A. Adjei, David H. Harpole, Ritu R. Gill, Charles B. Simone, Ellen Yorke, Andreas Rimner, Anne S. Tsao, B.C. John Cho, Andrew A. Jackson, Valerie W. Rusch, Harvey I. Pass, Marc de Perrot, Daniel R. Gomez, Fred R. Hirsch, Raphael Bueno, Mary Hesdorffer, David C. Rice, Kenneth E. Rosenzweig
Publikováno v:
Journal of Thoracic Oncology. 14:1172-1183
Introduction Detailed guidelines regarding the use of radiation therapy for malignant pleural mesothelioma (MPM) are currently lacking because of the rarity of the disease, the wide spectrum of clinical presentations, and the paucity of high-level da
Autor:
Ara A. Vaporciyan, Boris Sepesi, Garrett L. Walsh, Wayne L. Hofstetter, Reza J. Mehran, Eric Sceusi, Kyle G. Mitchell, Mara B. Antonoff, Erin M. Corsini, Stephen G. Swisher, Jack A. Roth, David C. Rice
Publikováno v:
Journal of thoracic disease. 11(8)
Background Thymic neuroendocrine tumors (NETs) are rare malignancies often treated in a multidisciplinary fashion. However, evidence for adjunctive therapy is limited, and predictors of survival and recurrence are not well established. Methods Patien
Autor:
Monique B. Nilsson, John V. Heymach, Reza J. Mehran, Brett W. Carter, Ignacio I. Wistuba, Lixia Diao, Maria I. Nunez, Jing Wang, Youhong Fan, J. Jack Lee, Heather Lin, Junya Fujimoto, Anne S. Tsao, S.G. Swisher, Ara Vaporcyan, David C. Rice, Waun Ki Hong
Publikováno v:
Journal of Thoracic Oncology. 13:246-257
Introduction Window of opportunity trials in malignant pleural mesothelioma (MPM) are challenging but can yield important translational information about a novel agent. Methods We treated patients with MPM (N = 24) with 4 weeks of oral dasatinib foll
Autor:
Daniel R. Gomez, Jiangong Niu, David C. Rice, Jack A. Roth, Scott M. Atay, David B. Nelson, Ara A. Vaporciyan, Stephen G. Swisher, Mara B. Antonoff, Garrett L. Walsh, Anne Tsao, Wayne L. Hofstetter, Reza J. Mehran, Sharon H. Giordano, Boris Sepesi
Publikováno v:
Journal of Clinical Oncology. 35:3354-3362
Purpose Small observational studies have shown a survival advantage to undergoing cancer-directed surgery for malignant pleural mesothelioma (MPM); however, it is unclear if these results are generalizable. Our purpose was to evaluate survival after
Autor:
Ara A. Vaporciyan, Garrett L. Walsh, Boris Sepesi, David C. Rice, Wayne L. Hofstetter, Reza J. Mehran, Stephen G. Swisher, Quynh Nhu Nguyen, Mara B. Antonoff, Arlene M. Correa
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 154:689-699
Objective For inoperable patients with pulmonary malignancy, stereotactic body radiotherapy is a reasonable therapeutic option. Despite good early tumor control, local failure occurs in up to 10% of patients by 3 years. Because management of local re
Autor:
Daniel R. Gomez, Lina Zhao, Z. Liao, Ritsuko Komaki, John V. Heymach, David C. Rice, Stephen M. Hahn, Melenda Jeter, James W. Welsh, Joe Y. Chang, Michael S. O'Reilly, Eric D. Brooks, Bing Sun
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 98:900-907
Purpose To discern the effectiveness and toxicity of stereotactic ablative radiation therapy (SABR) in the elderly population (aged ≥75 years) and to consider how SABR outcomes compare with surgical outcomes historically reported in the elderly. Me
Autor:
John V. Heymach, Bing Sun, Joe Y. Chang, Stephen M. Hahn, Kamran Ahrar, Melenda Jeter, Quynh Nhu Nguyen, Zhongxing Liao, George A. Eapen, Lina Zhao, Vivek Verma, Michael S. O'Reilly, James W. Welsh, Mara B. Antonoff, Daniel R. Gomez, Lei Feng, David C. Rice, Jeremy J. Erasmus, Eric D. Brooks
Publikováno v:
JAMA Network Open
Importance Stereotactic ablative radiotherapy (SABR) is first-line treatment for patients with early-stage non–small cell lung cancer (NSCLC) who cannot undergo surgery. However, up to 1 in 6 such patients will develop isolated local recurrence (iL
Autor:
Ara A. Vaporciyan, Bryan F. Meyers, Stephen G. Swisher, Mara B. Antonoff, Boris Sepesi, David C. Rice, Wayne L. Hofstetter, Jennifer M. Bell, Garrett L. Walsh, Reza J. Mehran, Arlene M. Correa
Publikováno v:
The Annals of Thoracic Surgery. 101:211-217
Background Management of superior sulcus non-small cell lung cancer (NSCLC) continues to evolve, with preoperative chemoradiotherapy (CXRT) followed by surgical intervention supported by several studies. Rates of pathologic complete response (pCR) ha
Autor:
Anthony P. Conley, Annikka Weissferdt, Wayne L. Hofstetter, Boris Sepesi, Kyle G. Mitchell, David C. Rice, David B. Nelson, Garrett L. Walsh, Jitesh B. Shewale, Stephen G. Swisher, Reza J. Mehran, Jack A. Roth, Mara B. Antonoff, Ara A. Vaporciyan
Publikováno v:
Journal of Surgical Oncology.
BACKGROUND AND OBJECTIVES Chest wall sarcomas are rare and may demonstrate heterogeneous features. Surgery remains the mainstay of treatment with chemotherapy and radiotherapy used as adjuncts. Herein, we report outcomes of a large cohort of patients
Autor:
Bing Sun, David C. Rice, J. Welsh, Peter A Balter, John V. Heymach, Stephen M. Hahn, Eric D. Brooks, Boris Sepesi, Melenda Jeter, Daniel R. Gomez, Mary Frances McAleer, Joe Y. Chang, Michael S. O'Reilly, Ritsuko Komaki, Zhongxing Liao
Objectives Our goal was to evaluate stereotactic ablative radiotherapy (SABR) as a salvage option for isolated recurrence of NSCLC in the lung parenchyma after definitive treatment of stage I to III disease. Methods Patients who had histologically co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec7875db790b1e02ab9ceae21791e731
https://europepmc.org/articles/PMC5881570/
https://europepmc.org/articles/PMC5881570/